Your browser doesn't support javascript.
loading
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.
Short, Nicholas J; Jabbour, Elias; Macaron, Walid; Ravandi, Farhad; Jain, Nitin; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Loghavi, Sanam; Haddad, Fadi G; Yilmaz, Musa; Issa, Ghayas C; Kebriaei, Partow; Kornblau, Steven M; Pelletier, Sarah; Flores, Wilmer; Matthews, Jairo; Garris, Rebecca; Kantarjian, Hagop.
Affiliation
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Macaron W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kebriaei P; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kornblau SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pelletier S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Flores W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Matthews J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garris R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 98(8): 1196-1203, 2023 08.
Article in En | MEDLINE | ID: mdl-37183966
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fusion Proteins, bcr-abl / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fusion Proteins, bcr-abl / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States